Literature DB >> 9815057

Properties of a Cl- current activated by cell swelling in rabbit portal vein vascular smooth muscle cells.

I A Greenwood1, W A Large.   

Abstract

In rabbit portal vein smooth muscle cells, application of a hypotonic external solution caused cell swelling and evoked an outwardly rectifying Cl- current. The hypotonicity-activated current was markedly reduced by the anti-estrogen tamoxifen (10 microM) and was inhibited by DIDS in a voltage-dependent manner [the concentration required to inhibit the current by 50% (IC50) at -50 and +100 mV was 21 and 5 microM DIDS, respectively]. Indanyloxyacetic acid 94 (IAA-94) and niflumic acid also inhibited the hypotonicity-activated current, with 50% inhibition produced at concentrations of approximately 200 and 100 microM, respectively. In isotonic conditions, application of tamoxifen and DIDS to cells decreased the holding current due to the inhibition of a resting conductance that was outwardly rectifying and reversed at the Cl- equilibrium potential. These data show that rabbit portal vein myocytes have a resting Cl- conductance that is enhanced by cell swelling; its possible physiological role is discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9815057     DOI: 10.1152/ajpheart.1998.275.5.H1524

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Swelling-activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressure.

Authors:  D G Welsh; M T Nelson; D M Eckman; J E Brayden
Journal:  J Physiol       Date:  2000-08-15       Impact factor: 5.182

2.  MONNA, a potent and selective blocker for transmembrane protein with unknown function 16/anoctamin-1.

Authors:  Soo-Jin Oh; Seok Jin Hwang; Jonghoon Jung; Kuai Yu; Jeongyeon Kim; Jung Yoon Choi; H Criss Hartzell; Eun Joo Roh; C Justin Lee
Journal:  Mol Pharmacol       Date:  2013-08-30       Impact factor: 4.436

3.  Selective inhibitory effects of niflumic acid on 5-HT-induced contraction of the rat isolated stomach fundus.

Authors:  H C Scarparo; G C Santos; J H Leal-Cardoso; D N Criddle
Journal:  Br J Pharmacol       Date:  2000-06       Impact factor: 8.739

4.  TMEM16A/ANO1 channels contribute to the myogenic response in cerebral arteries.

Authors:  Simon Bulley; Zachary P Neeb; Sarah K Burris; John P Bannister; Candice M Thomas-Gatewood; Wanchana Jangsangthong; Jonathan H Jaggar
Journal:  Circ Res       Date:  2012-08-07       Impact factor: 17.367

5.  Inhibition of volume-regulated anion channels in cultured endothelial cells by the anti-oestrogens clomiphene and nafoxidine.

Authors:  C Maertens; G Droogmans; P Chakraborty; B Nilius
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

6.  Functional inhibition of native volume-sensitive outwardly rectifying anion channels in muscle cells and Xenopus oocytes by anti-ClC-3 antibody.

Authors:  D Duan; J Zhong; M Hermoso; C M Satterwhite; C F Rossow; W J Hatton; I Yamboliev; B Horowitz; J R Hume
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

7.  Differential expression of volume-regulated anion channels during cell cycle progression of human cervical cancer cells.

Authors:  M R Shen; G Droogmans; J Eggermont; T Voets; J C Ellory; B Nilius
Journal:  J Physiol       Date:  2000-12-01       Impact factor: 5.182

8.  Modulation of volume-sensitive chloride current by noradrenaline in rabbit portal vein myocytes.

Authors:  D C Ellershaw; I A Greenwood; W A Large
Journal:  J Physiol       Date:  2002-07-15       Impact factor: 5.182

9.  Phosphorylation alters the pharmacology of Ca(2+)-activated Cl channels in rabbit pulmonary arterial smooth muscle cells.

Authors:  M Wiwchar; R Ayon; I A Greenwood; N Leblanc
Journal:  Br J Pharmacol       Date:  2009-09-28       Impact factor: 8.739

10.  Mechanisms of U46619- and 5-HT-induced contraction of bovine pulmonary arteries: role of chloride ions.

Authors:  V R Alapati; C McKenzie; A Blair; D Kenny; A MacDonald; A M Shaw
Journal:  Br J Pharmacol       Date:  2007-06-25       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.